Depo-Medrol on Psoas After LLIF

ConditionsMuscle Weakness Pain, Postoperative Paresthesia Pain, Muscle

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

Age18-75

SponsorHardeep Singh

About this trial

The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.

Eligibility criteria

Qualifiers

Patients from the practices of Drs. Singh, Mallozzi, Moss

Transpsoas (PTP or LTP) lateral lumbar interbody fusion (LLIF) 1-3 disc levels with posterior instrumentation (Open or MIS) with or without laminectomy, must include L3-4 and/or L4-5

Patients who agree to be a part of the study

Patients with lumbar disc degeneration

Disqualifiers

Scoliosis >10°

Spondylolisthesis >Grade 1

Flatback deformity

Patients with insulin dependent diabetes

Trial design

Treatments tested in this trial

Depo-Medrol
Gel-Flow NT

Treatment groups

80 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Hardeep Singh

Lead sponsor

UConn Health

Sponsor institution

Society for Minimally Invasive Spine Surgery

Collaborator

Source ClinicalTrials.gov